Japanese pharmaceutical company Eisai said on Tuesday that some of its servers were encrypted after the Eisai Group fell victim to a ransomware incident on Saturday, June 3.
As a result of the cyberattack, several systems, including logistics systems, were temporarily taken offline. Eisai’s corporate website and e-mail system are in operation, and the possibility of information leakage is currently under investigation.
Ransomware Attacks Deep DDoS, More Leaks: Ransomware Directions for 2023
Eisai said in a ransomware notice released on Tuesday that it is “currently carefully investigating the impact of this incident on its consolidated earnings forecasts for the current fiscal year.” “If we determine that a revision is necessary, we will make an announcement promptly.”
In response to this cyberattack, Eisai immediately set up a company-wide task force and is working on recovery under the guidance of external experts. They also involved law enforcement agencies in this matter.
“No organization wants a ransomware incident within their infrastructure, but having a robust security incident response program with a dedicated team that fully understands their roles and responsibilities should a ransomware incident occur By doing so, we can ensure that we can get back to work quickly,” commented security officer James McQuiggan. Awareness champion for KnowBe4.
The security expert also said that most successful cybercriminal group intrusion revelations were caused by insiders or nation states whose purpose was to steal data or cause serious disruption to the target organization. He suggested that it raises the question.
“Cybercriminals will continue to target pharmaceutical companies because their artifacts are important to society,” McKigan added.
“These organizations typically have large amounts of money to support them and are willing to steal any intellectual property to use to extort or ransom them.”
Pharmaceutical companies can learn more about protecting healthcare provider data with this analysis article by Michelle Teuscher, Head of Life Sciences Industry at Treasure Data.
Editorial image credit: Ralf Liebhold / Shutterstock.com
